Fox Christine Ann
SEC insider (Form 3/4/5 filer). CIK 0002005755. Chief Financial Officer at Mereo BioPharma Group plc (MREO). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 1, 2026. Located in LONDON, X0.
Companies Fox Christine Ann has filed insider reports for
- Mereo BioPharma Group plc (MREO): Officer, Chief Financial Officer
Fox Christine Ann
CIK: 0002005755
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mereo BioPharma Group plc
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Feb 1, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
315.8K shares- - Feb 1, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
280K shares- - Feb 1, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
105.3K shares- - Jan 25, 2025MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
262K shares- - Sep 13, 2024MREO
Mereo BioPharma Group plc
SaleDirect19.2K shares at avg. $4.22$81K - Sep 12, 2024MREO
Mereo BioPharma Group plc
SaleDirect9.1K shares at avg. $4.47$41K - Sep 11, 2024MREO
Mereo BioPharma Group plc
ExerciseDirect60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 315,750 | - | - | Direct |
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 280,000 | - | - | Direct |
| Feb 1, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 105,250 | - | - | Direct |
| Jan 25, 2025 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 262,000 | - | - | Direct |
| Sep 13, 2024 | MREO Mereo BioPharma Group plc | Sale | 19,158 | $4.22 | $80,866 | Direct |
| Sep 12, 2024 | MREO Mereo BioPharma Group plc | Sale | 9,128 | $4.47 | $40,827 | Direct |
| Sep 11, 2024 | MREO Mereo BioPharma Group plc | Exercise | 60,000 | - | $0 | Direct |
1-7 of 7 transactions